Improving prostate cancer control using personalized data
Modeling Precision Interventions for Prostate Cancer Control
['FUNDING_U01'] · FRED HUTCHINSON CANCER CENTER · NIH-10927278
This study is looking to improve how we manage prostate cancer by using personal health information to create better treatment plans, helping men at higher risk get the right care tailored just for them.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FRED HUTCHINSON CANCER CENTER (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10927278 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing prostate cancer management by utilizing personalized data to tailor interventions for patients. It aims to analyze various factors, including genetic testing and new biomarkers, to identify men at higher risk for aggressive disease and to optimize treatment strategies. By extending existing models from the Cancer Intervention and Surveillance Modeling Network, the research seeks to improve decision-making in prostate cancer screening and treatment. Patients may benefit from more accurate diagnoses and personalized treatment plans that consider their unique risk factors.
Who could benefit from this research
Good fit: Ideal candidates for this research include men diagnosed with prostate cancer, particularly those with low-risk disease or those considering active surveillance.
Not a fit: Patients with advanced prostate cancer who are not eligible for personalized treatment approaches may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for prostate cancer patients.
How similar studies have performed: Previous research has shown success in using personalized data to improve cancer treatment outcomes, indicating that this approach has potential.
Where this research is happening
SEATTLE, UNITED STATES
- FRED HUTCHINSON CANCER CENTER — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ETZIONI, RUTH D — FRED HUTCHINSON CANCER CENTER
- Study coordinator: ETZIONI, RUTH D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Cause, Cancer Control, Cancer Control Science, Cancer Etiology, Cancer Intervention